Back to trial details

Intake questionnaire

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Applying to HonorHealth Research Institute · Scottsdale, Arizona

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 55 and 85 years old?
2. Have you been diagnosed with Cognitive Dysfunction?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Scottsdale for study visits?